Search
Galapagos ADR Representing Ord Shs
LKFTAdd to Watchlist
29.480USD
+0.640+2.22%
Close 06/26, 16:00（ET）Quotes delayed by 15 min
1.94BMarket Cap
4.59P/E TTM
Earnings Forecast
Currency: USD Updated:Analyst Rating
Based on
3
analysts
Sell
Current Rating
28.000
Target Price
-2.91%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
561
Total
5
Median
6
Average
Company name
Ratings
Analysts
Galapagos ADR Representing Ord Shs
LKFT
3
CRISPR Therapeutics AG
CRSP
27
Ionis Pharmaceuticals Inc
IONS
27
Beigene Ltd
ONC
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
1
2
3
...
112
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Galapagos ADR Representing Ord Shs's expected revenue for the next quarter?
Galapagos ADR Representing Ord Shs's expected revenue is 9.92M.
How have Galapagos ADR Representing Ord ShsLKFT's recent earnings per share performed?
The market expectation was USD 0.25, while Galapagos ADR Representing Ord ShsLKFT's earnings per share (EPS) for the previous quarter was USD 5.72. EPS for the next quarter is expected at USD -1.31.
What is the analyst rating for Galapagos ADR Representing Ord Shs?
Based on the ratings of Galapagos ADR Representing Ord Shs's stock from 3 analysts, most analysts support a Sell trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Sell. Please note that this is not trading advice. You still need to conduct your own analysis.
